Page 4 of 8
Overall, 566 patients received at least one dose of the study medicines in the
maintenance phase. The study included 439 patients (78%) who were assigned male at
birth and 127 patients (22%) who were assigned female at birth. Of these, 437 patients
identified as male and 129 patients identified as female. The average age was 36 years.
The youngest patient was 18 years old and the oldest patient was 68 years old.
For more detailed information about the patients included in this study, see the
scientific results summaries (links to those summaries are provided at the end of this
document).
Where was this study done?
Study sites were in 11 countries.
Number of patients who received at least one dose of the
study medicines in the maintenance phase
Canada 23
France 43
Germany 44
Italy 38
Japan 20
Netherlands 5
Russian Federation 93
South Africa 32
Spain 157
United Kingdom 25
United States 86
0 40 80 120 160
Number of patients
What were the main results of the study?
Study doctors collected blood samples and measured patientsâ€™ viral load.